CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Drug Test Spurs Frank Talk Between Hypertension Patients and Doctors

Published: Fri, 20 Apr 2018 14:38:23 EDT
Roughly half of patients don’t take their high blood pressure medicine as they should, even though heart disease is the leading cause of death in America. Now, a drug test can flag whether a patient is taking the prescribed medication and is meant to spark a more truthful conversation between patient and doctor.
Kaiser Health News

Apr 20, 2018 This Week in Cardiology

Published: Fri, 20 Apr 2018 12:52:36 EDT
Ambulatory BP measurements, advanced practice providers, medical marijuana for sleep apnea, Barbara Bush's comfort care, and apixaban for cardioversion are the topics discussed in this week's podcast.
theheart.org on Medscape

Improving Outcomes Will Take More Than Clinical Care

Published: Fri, 20 Apr 2018 12:12:19 EDT
After Katrina, the New Orleans healthcare system had to be rebuilt. Partnerships with governments, churches, and social services led to the creation of an inventive, more resilient system.
Medscape Medical News
Displaying results 7-9 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

After questioning Lilly/Incyte's baricitinib, FDA director jumps ship to AstraZeneca

Published: Thu, 19 Apr 2018 21:02:34 +0000
The FDA’s Badrul Chowdhury is moving to AstraZeneca in the same week that he made a series of critical marks against Eli Lilly and Incyte's long-delayed baricitinib, which is set for an advisory committee on Monday.

Grail to seek an additional $1B in funding before Hong Kong IPO, report says

Published: Thu, 19 Apr 2018 15:03:24 +0000
Cancer blood test developer Grail is reportedly considering whether to squeeze in yet another billion-dollar funding round before it goes public in Hong Kong later this year, according to Bloomberg.

CNS Pharma turns to crowdfunding to advance glioblastoma drug

Published: Thu, 19 Apr 2018 12:53:03 +0000
CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor if phase 2 trials are positive.
Displaying results 7-9 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top